Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 658151, 10 pages
http://dx.doi.org/10.1155/2015/658151
Research Article

The Associations of Novel Vitamin D3 Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males

1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung 80708, Taiwan
2Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
3Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan
5Department of Urology, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung 80708, Taiwan
6Department of Urology, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
7Pingtung Hospital, Department of Health, Executive Yuan, Pingtung 90054, Taiwan
8Department of Pharmacy, China Medical University, Taichung 40402, Taiwan
9Department of Physical Therapy, Tzu Chi University, Hualien 97004, Taiwan
10Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

Received 1 May 2014; Revised 8 December 2014; Accepted 11 December 2014

Academic Editor: Maria L. Dufau

Copyright © 2015 Kai-Hung Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. C. Lee, C. C. Liu, C. N. Huang et al., “The potential impact of metabolic syndrome on erectile dysfunction in aging Taiwanese males,” The Journal of Sexual Medicine, vol. 7, no. 9, pp. 3127–3134, 2010. View at Google Scholar
  2. H. N. Ginsberg and P. R. Maccallum, “The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus,” Journal of the CardioMetabolic Syndrome, vol. 4, no. 2, pp. 113–119, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Malik and N. D. Wong, “Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis,” Expert Review of Cardiovascular Therapy, vol. 7, no. 3, pp. 273–280, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. L. Huang, “eNOS, metabolic syndrome and cardiovascular disease,” Trends in Endocrinology and Metabolism, vol. 20, no. 6, pp. 295–302, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. P. L. Huang, “A comprehensive definition for metabolic syndrome,” Disease Models and Mechanisms, vol. 2, no. 5-6, pp. 231–237, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. K.-H. Cheng, S.-P. Huang, C.-N. Huang et al., “The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males,” PLoS ONE, vol. 8, no. 3, Article ID e60295, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. W. Koenig, N. Khuseyinova, J. Baumert, C. Meisinger, and H. Löwel, “Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany,” Journal of the American College of Cardiology, vol. 48, pp. 1369–1377, 2006. View at Google Scholar
  8. S. H. Han, M. J. Quon, J.-A. Kim, and K. K. Koh, “Adiponectin and Cardiovascular Disease: Response to Therapeutic Interventions,” Journal of the American College of Cardiology, vol. 49, no. 5, pp. 531–538, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. Otsuka, S. Sugiyama, S. Kojima et al., “Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease,” Journal of the American College of Cardiology, vol. 48, no. 6, pp. 1155–1162, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. D. S. Frankel, R. S. Vasan, R. B. D'Agostino Sr. et al., “Resistin, adiponectin, and risk of heart failure. The Framingham Offspring Study,” Journal of the American College of Cardiology, vol. 53, no. 9, pp. 754–762, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. F. Ziemke and C. S. Mantzoros, “Adiponectin in insulin resistance: lessons from translational research,” The American Journal of Clinical Nutrition, vol. 91, no. 1, pp. 258S–261S, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. Barseghian, D. Gawande, and M. Bajaj, “Adiponectin and vulnerable atherosclerotic plaques,” Journal of the American College of Cardiology, vol. 57, no. 7, pp. 761–770, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Yamaguchi and T. Murata, “Involvement of regucalcin in lipid metabolism and diabetes,” Metabolism: Clinical and Experimental, vol. 62, no. 8, pp. 1045–1051, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. Wolk, P. Berger, R. J. Lennon, E. S. Brilakis, B. D. Johnson, and V. K. Somers, “Plasma leptin and prognosis in patients with established coronary atherosclerosis,” Journal of the American College of Cardiology, vol. 44, no. 9, pp. 1819–1824, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. S. Martin, A. Qasim, and M. P. Reilly, “Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease,” Journal of the American College of Cardiology, vol. 52, no. 15, pp. 1201–1210, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. N. Sattar, G. Wannamethee, N. Sarwar et al., “Leptin and coronary heart disease: prospective study and systematic review,” Journal of the American College of Cardiology, vol. 53, no. 2, pp. 167–175, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. Y.-C. Liao, K.-W. Liang, W.-J. Lee et al., “Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X,” Biomarkers, vol. 18, no. 1, pp. 44–50, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. J. Rasmussen-Torvik, C. L. Wassel, J. Ding et al., “Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the multi-ethnic study of atherosclerosis (MESA),” Annals of Epidemiology, vol. 22, no. 10, pp. 705–709, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. P. J. W. H. Kappelle, R. P. F. Dullaart, A. P. van Beek, H. L. Hillege, and B. H. R. Wolffenbuttel, “The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study,” European Journal of Internal Medicine, vol. 23, no. 8, pp. 755–759, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Kotani and N. Sakane, “Leptin: adiponectin ratio and metabolic syndrome in the general Japanese population,” The Korean Journal of Laboratory Medicine, vol. 31, no. 3, pp. 162–166, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. C. H. Jung, E. J. Rhee, J. H. Choi et al., “The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy Korean male adults,” Korean Diabetes Journal, vol. 34, no. 4, pp. 237–243, 2010. View at Google Scholar
  22. J. I. Botella-Carretero, F. Alvarez-Blasco, J. J. Villafruela, J. A. Balsa, C. Vázquez, and H. F. Escobar-Morreale, “Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity,” Clinical Nutrition, vol. 26, no. 5, pp. 573–580, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. K. Kim, M. Kang, K. W. Oh et al., “The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects,” Clinical Endocrinology (Oxford), vol. 73, no. 3, pp. 330–338, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. L. Lu, Z. Yu, A. Pan et al., “Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals,” Diabetes Care, vol. 32, no. 7, pp. 1278–1283, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. L. A. Martini and R. J. Wood, “Vitamin D status and the metabolic syndrome,” Nutrition Reviews, vol. 64, no. 11, pp. 479–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Judd and V. Tangpricha, “Vitamin D deficiency and risk for cardiovascular disease,” The American Journal of the Medical Sciences, vol. 338, no. 1, pp. 40–44, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. Vaidya, J. S. Williams, and J. P. Forman, “The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS,” Obesity, vol. 20, no. 1, pp. 186–191, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Vaidya, J. P. Forman, P. C. Underwood et al., “The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men,” European Journal of Endocrinology, vol. 164, no. 6, pp. 995–1002, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. B. Özkan, H. Döneray, and H. Keskin, “The effect of vitamin D treatment on serum adiponectin levels in children with vitamin D deficiency rickets,” Journal of Clinical Research in Pediatric Endocrinology, vol. 1, no. 6, pp. 262–265, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. K. Tsuji, T. Maeda, T. Kawane, A. Matsunuma, and N. Horiuchi, “Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice,” Journal of Bone and Mineral Research, vol. 25, no. 8, pp. 1711–1723, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. T. Sakaki, N. Kagawa, K. Yamamoto, and K. Inouye, “Metabolism of vitamin D3 by cytochromes P450,” Frontiers in Bioscience, vol. 10, no. 1, pp. 119–134, 2005. View at Google Scholar · View at Scopus
  32. C.-C. Liu, W.-J. Wu, Y.-C. Lee et al., “The prevalence of and risk factors for androgen deficiency in aging Taiwanese men,” Journal of Sexual Medicine, vol. 6, no. 4, pp. 936–946, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. C.-C. Liu, S.-P. Huang, W.-J. Wu et al., “The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis,” Annals of Epidemiology, vol. 19, no. 8, pp. 539–545, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. C.-H. Lee, D.-C. Wu, J.-M. Lee et al., “Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer,” International Journal of Cancer, vol. 120, no. 8, pp. 1755–1762, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. Ponholzer, C. Temml, M. Rauchenwald, and S. Madersbacher, “Vascular risk factors and erectile dysfunction in a cohort of healthy men,” International Journal of Impotence Research, vol. 18, no. 5, pp. 489–493, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. L.-C. Hwang, C.-H. Bai, and C.-J. Chen, “Prevalence of obesity and metabolic syndrome in Taiwan,” Journal of the Formosan Medical Association, vol. 105, no. 8, pp. 626–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. Kohli, M. Kirby, K. D. R. Setchell et al., “Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 299, no. 3, pp. G652–G660, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. T. Kangas-Kontio, A. Huotari, H. Ruotsalainen et al., “Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease,” Atherosclerosis, vol. 210, no. 2, pp. 479–485, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. Van Linthout, A. Foryst-Ludwig, F. Spillmann et al., “Impact of HDL on adipose tissue metabolism and adiponectin expression,” Atherosclerosis, vol. 210, no. 2, pp. 438–444, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. G. N. Gallus, M. T. Dotti, and A. Federico, “Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene,” Neurological Sciences, vol. 27, no. 2, pp. 143–149, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. I. Björkhem and M. Hansson, “Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge,” Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 46–49, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. G. Lorbek, M. Lewinska, and D. Rozman, “Cytochrome P450s in the synthesis of cholesterol and bile acids—from mouse models to human diseases,” FEBS Journal, vol. 279, no. 9, pp. 1516–1533, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. I. Björkhem, “Cerebrotendinous xanthomatosis,” Current Opinion in Lipidology, vol. 24, no. 4, pp. 283–287, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. Ahn, D. Albanes, S. I. Berndt et al., “Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk,” Carcinogenesis, vol. 30, no. 5, pp. 769–776, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. M. Lee, S. R. Kim, S. J. Yoo, O. K. Hong, H. S. Son, and S.-A. Chang, “The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes,” Journal of International Medical Research, vol. 37, no. 6, pp. 1803–1812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. D. M. Maahs, R. F. Hamman, R. D'Agostino Jr. et al., “The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study,” Journal of Pediatrics, vol. 155, no. 1, pp. 133–135, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. Stofkova, “Leptin and adiponectin: From energy and metabolic dysbalance to inflammation and autoimmunity,” Endocrine Regulations, vol. 43, no. 4, pp. 157–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Procaccini, E. Jirillo, and G. Matarese, “Leptin as an immunomodulator,” Molecular Aspects of Medicine, vol. 33, no. 1, pp. 35–45, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. A. Batra, B. Okur, R. Glauben et al., “Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo,” Endocrinology, vol. 151, no. 1, pp. 56–62, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. N. Iikuni, Q. L. K. Lam, L. Lu, G. Matarese, and A. La Cava, “Leptin and inflammation,” Current Immunology Reviews, vol. 4, no. 2, pp. 70–79, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. A. V. Baranova, “Adipokine genetics: unbalanced protein secretion by human adipose tissue as a cause of the metabolic syndrome,” Genetika, vol. 44, no. 10, pp. 1338–1355, 2008. View at Google Scholar · View at Scopus